SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : genelabs(gnlb) -- Ignore unavailable to you. Want to Upgrade?


To: Secret_Agent_Man who wrote (196)2/21/2000 1:13:00 PM
From: Dave C  Respond to of 233
 
Is the current timeline of GL331 years out? I do not have a medical background, so am totally unfamiliar with the clinical process/timeline?

Also, is Genelabs approach (selective gene analysis, verse random gene analysis) unique or proprietary or is this philosophy the norm in these companies?

Thanks for your information, while I don't pretend to understand all of the technical talk, it does help greatly in understanding the company.

Regards Dave



To: Secret_Agent_Man who wrote (196)2/21/2000 11:11:00 PM
From: Secret_Agent_Man  Read Replies (1) | Respond to of 233
 
Byron C. Glenn, M.D.